Balanced news tone
News Sentiment
1548 sentiment intelligence
Genscript Biotech Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
93/100 classification confidence.
directly relevant articles
high-authority source matches
+1.7% over one week, +6.3% over four weeks, trend active, and near fair-value range.
Genscript Biotech (SEHK:1548) Valuation Check After Recent Share Price Pullback
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Genscript Biotech (SEHK:1548) Valuation Check After Recent Share Price Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
GenScript rally underscores China’s rise in cancer drug innovation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- South China Morning Post
Stock Movement | Genscript Biotech (01548) Surges Over 5% as Affiliate Legend Biotech Narrows Q1 Loss, CARVYKTI Net Sales Increase by 60%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- 富途牛牛
A Look At Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Momentum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 May 2026 07:00
- Source
- simplywall.st
Genscript’s 2025 Profit Swing And mRNA Expansion Might Change The Case For Investing In Genscript Biotech (SEHK:1548)
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- simplywall.st
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Chinese biotech ETFs attract investors amid US$60 billion of licensing deals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Sep 2025 07:00
- Source
- South China Morning Post
GenScript Biotech jumps on associate's Carvykti sales beat
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2025 07:00
- Source
- TradingView
Amid geopolitical tensions, Legend sheds GenScript as its majority shareholder
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Oct 2024 07:00
- Source
- Fierce Pharma
GenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese Ties
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2024 07:00
- Source
- WSJ
FAST NEWS: Genscript’s controlling shareholder sells shares to Hillhouse Capital
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Dec 2023 08:00
- Source
- thebambooworks.com
GenScript Named a BioSpace 2024 Best Place to Work
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Dec 2023 08:00
- Source
- BioSpace
GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Aug 2023 07:00
- Source
- PR Newswire
Genscript, Legend Biotech founder arrested in China for suspected smuggling
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Nov 2020 08:00
- Source
- Fierce Pharma
Genscript slumps after chairman’s arrest on suspected smuggling offence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Nov 2020 08:00
- Source
- South China Morning Post
Genscript shares plunge after chairman placed under ‘residential surveillance’
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Sep 2020 07:00
- Source
- South China Morning Post
GenScript Shares Drop on Report Alleging Safety Violations by Unit Partnered With Johnson & Johnson
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Sep 2018 07:00
- Source
- WSJ
Technical Analysis of Genscript Biotech Corporation (HKEX:1548)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Feb 2018 07:16
- Source
- TradingView
Genscript shares surge on US$350m Johnson & Johnson tie-up
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Dec 2017 08:00
- Source
- South China Morning Post
GENSCRIPT BIOTECH CORPORATION (1548)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Dec 2015 08:00
- Source
- hkex.com.hk